Vegato Pharma
CEO Message
Helping valuable work find its opportunity—and fulfil its promise.
Thank you for your interest in VEGATO Pharma. Established in October 2026, VEGATO Pharma is a B2B business development and partnering company connecting international pharmaceutical and healthcare products and technologies with businesses in Korea. We help international companies find the right partners in the Korean market and Korean companies access the products and technologies they need to grow.
Behind every product and technology are years of effort: researchers who persevered through setbacks, companies that invested with conviction, and people who believed their work could make a meaningful difference. Companies seeking new assets face an equally important responsibility—to secure their future and create new opportunities for growth. We founded VEGATO Pharma out of respect for those efforts and a commitment to helping both partners realise their ambitions.
Our mission is to create fertile ground where the efforts and capabilities of both partners can take root and flourish together. This begins with understanding what each partner has built, what they hope to achieve, and what they need to move forward. By bringing valuable assets and complementary capabilities together, we help lay the foundations for sustainable business. We believe the ultimate purpose of this work is fulfilled when these partnerships offer better choices to patients and consumers.
We put this belief into practice through careful assessment, candid communication, and consistent delivery. We examine scientific evidence and market fit, discussing challenges as openly as opportunities. We help structure partnerships around each company’s objectives and capabilities, paying close attention to the commitments that make an agreement workable. From early discussions through to implementation, we work with our partners to turn shared intentions into concrete action.
Our partners entrust us with more than products and information. They entrust us with the results of years of work and their hopes for what comes next. We never forget that our judgment, our words, and our commitments can influence that future. When questions remain, we investigate further. When difficulties arise, we work through them alongside our partners. We follow through on what we promise and remain accountable for the work we undertake.
VEGATO’s six principles—Value Validation, Evidence Evaluation, Global Partnering, Agreement Architecture, Trust and Transparency, and Operational Stewardship—guide our daily decisions and actions. Guided by these principles, we aim to earn a simple expression of confidence from our partners: “They understood our ambitions, and we could count on them when it mattered.”
We want the dedication of international companies to find opportunity in Korea, and the ambitions of Korean businesses to gain strength through the right products and technologies. We will prepare each partnership with care, honour the trust placed in us, and work alongside our partners to fulfil its promise.
Alex (Dukkwon) Won
Founder & CEO
VEGATO Pharma Co., Ltd.
